Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 14 studies | 29% ± 13% | |
dendritic cell | 4 studies | 30% ± 13% |
Insufficient scRNA-seq data for expression of CBFA2T3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 1305.77 | 242 / 245 | 98% | 8.09 | 494 / 502 |
pancreas | 100% | 2293.83 | 328 / 328 | 88% | 4.07 | 157 / 178 |
breast | 100% | 1378.47 | 459 / 459 | 86% | 7.69 | 964 / 1118 |
lung | 100% | 2121.72 | 578 / 578 | 84% | 3.60 | 967 / 1155 |
thymus | 99% | 750.44 | 645 / 653 | 80% | 17.19 | 484 / 605 |
brain | 93% | 1867.67 | 2463 / 2642 | 83% | 2.67 | 588 / 705 |
esophagus | 96% | 650.93 | 1387 / 1445 | 75% | 3.09 | 138 / 183 |
uterus | 100% | 856.15 | 170 / 170 | 71% | 3.39 | 325 / 459 |
intestine | 98% | 1065.83 | 950 / 966 | 67% | 3.98 | 354 / 527 |
bladder | 100% | 666.90 | 21 / 21 | 60% | 2.91 | 304 / 504 |
stomach | 92% | 514.74 | 330 / 359 | 67% | 2.81 | 193 / 286 |
adrenal gland | 66% | 326.32 | 170 / 258 | 81% | 4.43 | 186 / 230 |
liver | 84% | 535.23 | 190 / 226 | 41% | 1.17 | 168 / 406 |
skin | 71% | 470.80 | 1291 / 1809 | 49% | 2.13 | 233 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.46 | 29 / 29 |
spleen | 100% | 4060.55 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1222.35 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 1153.98 | 854 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 836.63 | 789 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1921.15 | 905 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 4.06 | 42 / 45 |
kidney | 36% | 154.09 | 32 / 89 | 56% | 1.36 | 508 / 901 |
ovary | 25% | 95.72 | 45 / 180 | 37% | 1.04 | 157 / 430 |
blood vessel | 40% | 199.90 | 528 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 0.20 | 9 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045820 | Biological process | negative regulation of glycolytic process |
GO_1903715 | Biological process | regulation of aerobic respiration |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0030851 | Biological process | granulocyte differentiation |
GO_0001666 | Biological process | response to hypoxia |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005730 | Cellular component | nucleolus |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CBFA2T3 |
Protein name | Protein CBFA2T3 (MTG8-related protein 2) (Myeloid translocation gene on chromosome 16 protein) (hMTG16) (Zinc finger MYND domain-containing protein 4) CBFA2/RUNX1 partner transcriptional co-repressor 3 |
Synonyms | MTGR2 MTG16 ZMYND4 |
Description | FUNCTION: Transcriptional corepressor which facilitates transcriptional repression via its association with DNA-binding transcription factors and recruitment of other corepressors and histone-modifying enzymes . Can repress the expression of MMP7 in a ZBTB33-dependent manner . Reduces the protein levels and stability of the transcriptinal regulator HIF1A; interacts with EGLN1 and promotes the HIF1A prolyl hydroxylation-dependent ubiquitination and proteasomal degradation pathway . Contributes to inhibition of glycolysis and stimulation of mitochondrial respiration by down-regulating the expression of glycolytic genes including PFKFB3, PFKFB4, PDK1, PFKP, LDHA and HK1 which are direct targets of HIF1A . Regulates the proliferation and the differentiation of erythroid progenitors by repressing the expression of TAL1 target genes (By similarity). Plays a role in granulocyte differentiation . .; FUNCTION: Isoform 2 functions as an A-kinase-anchoring protein . . |
Accessions | ENST00000562719.5 H3BR72 H3BMZ0 ENST00000569443.5 ENST00000566868.1 ENST00000570046.1 ENST00000268679.9 [O75081-1] ENST00000327483.9 [O75081-2] ENST00000564416.1 ENST00000569464.5 ENST00000563640.1 H3BU07 H3BNH2 J3QRB1 H3BSI4 O75081 H3BNI7 |